Maira Imtiaz

The total value and volume of private equity and venture capital deals in the global education services sector fell roughly 47% and 40%, respectively, year over year in 2023.

Venture capital funding rounds in April saw a year-over-year decrease in transaction value, falling to $17.20 billion compared to $19.12 billion in April 2023, according to data from S&P Global Market Intelligence.

The total value of private equity and venture capital deals in the enterprise software sector dropped 51% year over year in 2023, the lowest total value since 2019.

Kirkland & Ellis nabbed first place in the legal adviser ranking for the top global private equity and venture capital deals in the first quarter.

The monthly aggregate value and volume of venture capital deals also declined in March.

The total value of private equity and venture capital deals in the Middle East closed at $11.60 billion in 2023, marking a 26% decline from 2022.

February saw announcements of global private equity and venture capital entries with an aggregate value of $59.59 billion, up 125.7% month over month and 114.3% year over year.

Venture capital funding rounds in January saw a year-on-year increase in transaction value, reaching $22.11 billion compared to $21.30 billion in January 2023, according to data from S&P Global Market Intelligence.

Japan logged private equity and venture capital-backed deal value of $8.56 billion in 2023, the lowest annual total since 2020, according to S&P Global Market Intelligence data.

Private equity and venture capital investment across the biotechnology sector dropped in both deal value and volume, with the lowest annual value since 2019, according to S&P Global Market Intelligence data.

US private equity-backed deal value in the sector dropped by more than half to $620 million, the lowest annual total since 2019, according to S&P Global Market Intelligence data.

The trio jointly occupied the highest position in the ranking of financial advisers for the largest global private equity and venture capital deals in 2023.

S&P Global Market Intelligence’s most read private equity stories show the industry’s resilience amid diverse challenges in 2023.

Private equity investments across the global healthcare technology sector for the year through Nov. 23 stood at $9.18 billion, down 37% compared to full year 2022, according to S&P Global Market Intelligence data.

Global drug retail saw a sharp decline in private equity and venture capital investments year through Oct. 22, with deal value totaling $560 million compared to $2.23 billion in 2022.